| Autor: |
Claeys, Marc J., Van der Planken, Marc G., Bosmans, Johan M., Michiels, Jan J., Vertessen, Francine, Van Der Goten, Peter, Wuyts, Floris L., Vrints, Chris J. |
| Zdroj: |
European Heart Journal; Mar2005, Vol. 26 Issue 6, p567-575, 9p |
| Abstrakt: |
Aims Although full platelet inhibition with aspirin and thienopyridines before coronary stenting has significantly reduced the risk of acute stent thrombosis, peri-procedural myonecrosis still occurs frequently and is associated with increased death rate. Whether further inhibition of platelet aggregation by a glycoprotein IIb/IIIa antagonist may provide an additional cardioprotection is unknown. [ABSTRACT FROM PUBLISHER] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
